Stem gene expression in breast tumors during chemotherapy: Connection with the main clinical and morphological factors and the disease outcome.

Autor: Ibragimova MK; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences; National Research Tomsk State University, Tomsk, Russia., Tsyganov MM; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia., Deryusheva IV; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia., Slonimskaya EM; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia., Litviakov NV; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk, Russia.

Publikováno v: Journal of cancer research and therapeutics [J Cancer Res Ther] 2022 Jan-Mar; Vol. 18 (1), pp. 89-95.

Genome-wide methylotyping resolves breast cancer epigenetic heterogeneity and suggests novel therapeutic perspectives.

Autor: Tanas AS; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Molecular & Cell Genetics Department, Pirogov Russian National Research Medical University, Moscow, Russia., Sigin VO; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Kalinkin AI; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Medical Genetics Laboratory, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Litviakov NV; Laboratory of Oncovirology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Slonimskaya EM; Department of General Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Ibragimova MK; Laboratory of Oncovirology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Ignatova EO; Clinical Pharmacology & Chemotherapy, Federal State Budgetary institution «N.N. Blokhin National Medical Research Center of Oncology» of the Ministry of Health of the Russian Federation, Moscow, Russia., Simonova OA; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Kuznetsova EB; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Medical Genetics Laboratory, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Kekeeva TV; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Larin SS; Gene Therapy Laboratory, Institute of Gene Biology, Moscow, Russia.; Molecular Immunology Laboratory, Federal Scientific Clinical Centre of Pediatric Hematology Oncology Immunology Named after Dmitry Rogachev, Moscow, Russia., Poddubskaya EV; Clinic of Personalized Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia.; VitaMed LLC, Moscow, Russia., Trotsenko ID; Institute of Medicine, RUDN University, Moscow, Russia., Rudenko VV; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Karandasheva KO; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Petrova KD; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Department of Biological and Medical Physics, Moscow Institute of Physics & Technology (State University), Dolgoprudny, Moscow Region, Russia., Tsyganov MM; Laboratory of Oncovirology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Deryusheva IV; Laboratory of Oncovirology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Kazantseva PV; Department of General Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Doroshenko AV; Department of General Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Tarabanovskaya NA; Department of General Oncology, Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia., Chesnokova GG; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Sekacheva MI; Clinic of Personalized Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Nemtsova MV; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Medical Genetics Laboratory, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Izhevskaya VL; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia., Kutsev SI; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Molecular & Cell Genetics Department, Pirogov Russian National Research Medical University, Moscow, Russia., Zaletaev DV; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Molecular & Cell Genetics Department, Pirogov Russian National Research Medical University, Moscow, Russia.; Medical Genetics Laboratory, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Strelnikov VV; Epigenetics Laboratory, Research Centre for Medical Genetics, Moscow, Russia.; Molecular & Cell Genetics Department, Pirogov Russian National Research Medical University, Moscow, Russia.

Publikováno v: Epigenomics [Epigenomics] 2019 May; Vol. 11 (6), pp. 605-617. Date of Electronic Publication: 2019 Feb 07.

Genome-wide association study of loss of heterozygosity and metastasis-free survival in breast cancer patients.

Autor: Deryusheva IV; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia., Tsyganov M; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia., Garbukov EY; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia., Ibragimova MK; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia., Kzhyshkovska JG; Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, Heidelberg University; German Red Cross Blood Service Baden-Württemberg - Hessen; Mannheim, Germany., Slonimskaya E; Cancer Research Institute, Tomsk National Research Medical Center of the Russian Academy of Sciences, Tomsk 634050, Russia., Cherdyntseva NV; National Research Tomsk State University, Tomsk 634050, Russia., Litviakov NV; National Research Tomsk State University, Tomsk 634050, Russia.

Publikováno v: Experimental oncology [Exp Oncol] 2017 Jul; Vol. 39 (2), pp. 145-150.

Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on SARS-COV-2 and lung adenocarcinoma crosstalk genes.

Autor: Wu Y; School of Public Health, North China University of Science and Technology, Tangshan, China., Cui Y; School of Public Health, North China University of Science and Technology, Tangshan, China., Zheng X; School of Public Health, North China University of Science and Technology, Tangshan, China., Yao X; School of Public Health, North China University of Science and Technology, Tangshan, China., Sun G; School of Public Health, North China University of Science and Technology, Tangshan, China.

Publikováno v: Cancer science [Cancer Sci] 2024 Nov 03. Date of Electronic Publication: 2024 Nov 03.

Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors.

Autor: Mekonnen, Negesse, Yang, Hobin, Shin, Young Kee

Publikováno v: Frontiers in Oncology; 6/17/2022, Vol. 12, p1-28, 28p